These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 15274850

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Ben-Dov IZ, Mekler J, Ben-Arie L, Bursztyn M.
    Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
    [Abstract] [Full Text] [Related]

  • 4. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
    Babić BK, Bagatin J, Kokić S, Ostojić SB, Carević V, Berović N.
    Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The white coat effect in primary care. Analysis of patients with newly diagnosed arterial hypertension].
    Mayoral E, Lapetra J, Santos JM, López A, Ruiz J, Cayuela A.
    Med Clin (Barc); 1997 Apr 05; 108(13):485-9. PubMed ID: 9235424
    [Abstract] [Full Text] [Related]

  • 8. White coat effect in treated hypertensive patients: sex differences.
    Myers MG, Reeves RA.
    J Hum Hypertens; 1995 Sep 05; 9(9):729-33. PubMed ID: 8551486
    [Abstract] [Full Text] [Related]

  • 9. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep 05; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M, Ruxer J, Barański M, Roszczyk N, Markuszewski L.
    Ann Acad Med Stetin; 2008 Sep 05; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of the white-coat effect at multiple visits before and during treatment.
    Verberk WJ, Kroon AA, Thien T, Lenders JW, van Montfrans GA, Smit AJ, de Leeuw PW.
    J Hypertens; 2006 Dec 05; 24(12):2357-63. PubMed ID: 17082716
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA, Hatzigeorgiou C.
    Ann Pharmacother; 2011 Jul 05; 45(7-8):910-5. PubMed ID: 21750311
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?
    Lorgelly P, Siatis I, Brooks A, Slinn B, Millar-Craig MW, Donnelly R, Manning G.
    Br J Gen Pract; 2003 Oct 05; 53(495):794-6. PubMed ID: 14601356
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.